Biofrontera Inc. Common Stock

BFRI XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

13M

Short interest (Apr 30)

0.7%

Net Short (Jun 03 ): -0.1%

Borrow Fee

1.36%

↓ 43.4%

Available Shares

700K

↑ 5.0%

Price Chart

Company Overview

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0001858685
Asset Type: CS

Market Data

Market Cap: $13,187,444
Employees: 94
Status: Active

Short Interest

Current Borrow Fee 1.36%
Range: 1.31% - 1.36%
Available Shares 700K
Range: 450K - 700K

Recent Changes

Fee Change: ↑ 1.1%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime